Active substance
Desonide
- US FDA 25
- Health Canada 2
- US price lines 6
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DESONIDE | 0.05% | ointment · topical | PADAGIS US | Prescription | 1 Nov 1974 |
| DESOWEN | 0.05% | cream · topical | GALDERMA LABS LP | Prescription | 14 Dec 1984 |
| DESONIDE | 0.05% | cream · topical | SUN PHARMA CANADA | Prescription | 30 Jun 1992 |
| DESONIDE | 0.05% | cream · topical | COSETTE PHARMS NC | Prescription | 28 Sep 1992 |
| DESONIDE | 0.05% | ointment · topical | SUN PHARMA CANADA | Prescription | 3 Aug 1994 |
| DESONIDE | 0.05% | ointment · topical | FOUGERA PHARMS | Prescription | 12 Mar 2001 |
| DESONIDE | 0.05% | lotion · topical | FOUGERA PHARMS | Prescription | 19 Mar 2002 |
| DESONIDE | 0.05% | lotion · topical | TARO | Prescription | 31 Oct 2014 |
| DESONIDE | 0.05% | ointment · topical | ENCUBE ETHICALS | Prescription | 30 Jan 2019 |
| DESONIDE | 0.05% | ointment · topical | ALEMBIC | Prescription | 23 Oct 2019 |
| DESONIDE | 0.05% | cream · topical | CADILA | Prescription | 20 Nov 2019 |
| DESONIDE | 0.05% | gel · topical | SENORES PHARMS | Prescription | 11 May 2020 |
| DESONIDE | 0.05% | lotion · topical | ALEMBIC | Prescription | 24 Aug 2020 |
| DESONIDE | 0.05% | cream · topical | ALEMBIC | Prescription | 8 Dec 2022 |
| DESONIDE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream · topical | PADAGIS US | Discontinued | 4 Jan 1972 |
| DESOWEN | 0.05% | ointment · topical | GALDERMA LABS LP | Discontinued | 15 Jun 1988 |
| DESOWEN | 0.05% | lotion · topical | GALDERMA LABS LP | Discontinued | 24 Jan 1992 |
| VERDESO | 0.05% | aerosol, foam · topical | GENUS | Discontinued | 19 Sep 2006 |
| DESONATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | gel · topical | LEO PHARMA AS | Discontinued | 20 Oct 2006 |
| DESONIDE | 0.05% | ointment · topical | HIKMA PHARMS | Discontinued | 27 Mar 2017 |
| DESONIDE | 0.05% | cream · topical | GLENMARK SPECLT | Discontinued | 24 Jul 2017 |
| DESONIDE | 0.05% | ointment · topical | GLENMARK PHARMS LTD | Discontinued | 15 Sep 2017 |
| DESONIDE | 0.05% | lotion · topical | GLENMARK SPECLT | Discontinued | 26 Sep 2017 |
| DESONIDE | 0.05% | lotion · topical | ENCUBE | Discontinued | 28 Sep 2017 |
| DESONIDE | 0.05% | ointment · topical | PAI HOLDINGS PHARM | Discontinued | 12 Mar 2019 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| PDP-DESONIDE | 02229315 | 0.05 % / W/W | CREAM · TOPICAL | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| PDP-DESONIDE | 02229323 | 0.05 % / W/W | OINTMENT · TOPICAL | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DESONIDE 0.05% CREAM | $0.30564 | per GM | 23 Sep 2026 |
| US NADAC | DESONIDE 0.05% CREAM | $0.19737 | per GM | 23 Sep 2026 |
| US NADAC | DESONIDE 0.05% LOTION | $0.54038 | per ML | 23 Sep 2026 |
| US NADAC | DESONIDE 0.05% LOTION | $0.52466 | per ML | 23 Sep 2026 |
| US NADAC | DESONIDE 0.05% OINTMENT | $0.3921 | per GM | 23 Sep 2026 |
| US NADAC | DESONIDE 0.05% OINTMENT | $0.25659 | per GM | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 15 Apr 2019 VERDESO — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.